These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 3428863)
1. Biopsy histamine in ulcerative colitis and Crohn's disease. Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
3. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease. Szewczuk MR; Depew WT Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis. Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628 [TBL] [Abstract][Full Text] [Related]
5. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Bernstein CN; Robert ME; Eysselein VE Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884 [TBL] [Abstract][Full Text] [Related]
6. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Yantiss RK; Das KM; Farraye FA; Odze RD Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596 [TBL] [Abstract][Full Text] [Related]
7. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968 [TBL] [Abstract][Full Text] [Related]
8. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T; Voigt E; Gretzer B; Brasch F; May B Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335 [TBL] [Abstract][Full Text] [Related]
10. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Banks C; Bateman A; Payne R; Johnson P; Sheron N J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223 [TBL] [Abstract][Full Text] [Related]
11. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. Strugala V; Dettmar PW; Pearson JP Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279 [TBL] [Abstract][Full Text] [Related]
12. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease. Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012 [TBL] [Abstract][Full Text] [Related]
13. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis. Schmitz-Moormann P; Himmelmann GW; Brandes JW Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239 [TBL] [Abstract][Full Text] [Related]
14. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. Kruidenier L; Kuiper I; Lamers CB; Verspaget HW J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014 [TBL] [Abstract][Full Text] [Related]
15. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
16. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515 [TBL] [Abstract][Full Text] [Related]
17. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130 [TBL] [Abstract][Full Text] [Related]